Golden
Exosome Diagnostics

Exosome Diagnostics

A company developing and commercializing cancer molecular diagnostics based isolation of exosomes from body fluids. Exosome Diagnostics was founded in 2008.

Exosome Diagnostics isolates exosomes, cell-derived vesicles, which contain RNA, DNA and proteins, from serum, plasma, urine, cerebralspinal fluid and saliva. The company performs molecular analysis of exosomes for diagnotics, disease detection, treatment and monitoring. Exosome Diagnostics collaborates with pharmaceutical companies such as Amgen and Takeda in research and development, biomarker discovery, validation and development of diagnostics. 



While Chief Scientific Officer Johan Skog was at Massachusetts General Hospital, he was the first to demonstrate the detection of molecular mutations in a tumor in RNA extracted from exosomes in Nature Cell Biology in 2008. 



Timeline

Funding rounds

2 Results
Funding round
Funding round
Funding round amount (USD)
Funding round amount (USD)
Funding type
Funding type
Funding round date
Funding round date
Investment
Investment

People

Name
Role
LinkedIn

Johan Skog

Founding Scientist, CSO



John Healy

Employee



Mikkel Noerholm, PhD

VP Product Development



Thomas McLain, MBA, CPA

General Manager



William J. Kelly, CPA

CFO



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References